Intellia Therapeutics has revealed that a single infusion of its experimental CRISPR therapy, called NTLA-2002, almost entirely eliminated swelling attacks in 10 people with hereditary …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Note that some links may require registration or subscription. Also please note that in observance of the upcoming holiday, Morning Break will not publish on
An implantable sensor provided advanced warning of kidney transplant failure in rats as much as several weeks earlier than commonly used biomarkers of kidney function,
Even though COVID-19 manifests as a mild and short-lived disease in most people, some suffer extremely severe symptoms; in the worst cases, these patients die